89Bio Inc. has announced that, in connection with the closing of a merger, it has notified the Nasdaq Global Market of the completion of the transaction and requested that trading of its shares be halted and the shares be delisted before the opening of trading on October 30, 2025. The company also intends to file a Form 25 with the SEC to remove its shares from listing and registration, and subsequently file a Form 15 to terminate the registration of its shares and suspend its SEC reporting obligations.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 89Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-257616), on October 30, 2025, and is solely responsible for the information contained therein.